These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1006 related articles for article (PubMed ID: 22329651)
21. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics. Di Domenico F; Barone E; Perluigi M; Butterfield DA Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216 [TBL] [Abstract][Full Text] [Related]
22. Insulin resistance: an emerging link in Alzheimer's disease. Medhi B; Chakrabarty M Neurol Sci; 2013 Oct; 34(10):1719-25. PubMed ID: 23670236 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease. de la Monte SM; Tong M J Alzheimers Dis; 2009; 17(4):817-25. PubMed ID: 19542621 [TBL] [Abstract][Full Text] [Related]
24. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease. Freude S; Schilbach K; Schubert M Curr Alzheimer Res; 2009 Jun; 6(3):213-23. PubMed ID: 19519303 [TBL] [Abstract][Full Text] [Related]
25. Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function -- role of glucose metabolism and insulin signalling. Rhein V; Eckert A Arch Physiol Biochem; 2007 Jun; 113(3):131-41. PubMed ID: 17922309 [TBL] [Abstract][Full Text] [Related]
26. Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review. Berlanga-Acosta J; Guillén-Nieto G; Rodríguez-Rodríguez N; Bringas-Vega ML; García-Del-Barco-Herrera D; Berlanga-Saez JO; García-Ojalvo A; Valdés-Sosa MJ; Valdés-Sosa PA Front Endocrinol (Lausanne); 2020; 11():560375. PubMed ID: 33224105 [TBL] [Abstract][Full Text] [Related]
27. Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease. Zhao WQ; Townsend M Biochim Biophys Acta; 2009 May; 1792(5):482-96. PubMed ID: 19026743 [TBL] [Abstract][Full Text] [Related]
28. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371 [TBL] [Abstract][Full Text] [Related]
29. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model. Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967 [TBL] [Abstract][Full Text] [Related]
30. The Link between Type 2 Diabetes and Neurodegeneration: Roles for Amyloid-β, Amylin, and Tau Proteins. Bharadwaj P; Wijesekara N; Liyanapathirana M; Newsholme P; Ittner L; Fraser P; Verdile G J Alzheimers Dis; 2017; 59(2):421-432. PubMed ID: 28269785 [TBL] [Abstract][Full Text] [Related]
31. AMPK: A bridge between diabetes mellitus and Alzheimer's disease. Chen M; Huang N; Liu J; Huang J; Shi J; Jin F Behav Brain Res; 2021 Feb; 400():113043. PubMed ID: 33307136 [TBL] [Abstract][Full Text] [Related]
32. [Alzheimer's disease and diabetes - the common pathogenesis]. Halmos T; Suba I Neuropsychopharmacol Hung; 2016 Mar; 18(1):5-19. PubMed ID: 27038867 [TBL] [Abstract][Full Text] [Related]
33. The metabolism hypothesis of Alzheimer's disease: from the concept of central insulin resistance and associated consequences to insulin therapy. Morgen K; Frölich L J Neural Transm (Vienna); 2015 Apr; 122(4):499-504. PubMed ID: 25673434 [TBL] [Abstract][Full Text] [Related]
35. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease. Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165 [TBL] [Abstract][Full Text] [Related]
36. Role of insulin resistance in Alzheimer's disease. Cai Z; Xiao M; Chang L; Yan LJ Metab Brain Dis; 2015 Aug; 30(4):839-51. PubMed ID: 25399337 [TBL] [Abstract][Full Text] [Related]
37. Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. Salkovic-Petrisic M; Hoyer S J Neural Transm Suppl; 2007; (72):217-33. PubMed ID: 17982898 [TBL] [Abstract][Full Text] [Related]
38. Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. Moroz N; Tong M; Longato L; Xu H; de la Monte SM J Alzheimers Dis; 2008 Sep; 15(1):29-44. PubMed ID: 18780965 [TBL] [Abstract][Full Text] [Related]
39. Effects of Chronic Arginase Inhibition with Norvaline on Tau Pathology and Brain Glucose Metabolism in Alzheimer's Disease Mice. Polis B; Squillario M; Gurevich V; Srikanth KD; Assa M; Samson AO Neurochem Res; 2022 May; 47(5):1255-1268. PubMed ID: 35098420 [TBL] [Abstract][Full Text] [Related]